133. Sickle Cell Disease: Shifting Paradigms in Optimal Management for NPs (CE)

12/11/24 • 63 min

NP Pulse: The Voice of the Nurse Practitioner (AANP)

Sickle cell disease (SCD) is a condition of immense and multifarious clinical gravity causing acute pain, joint damage, anemia and risk of infection, stroke, delayed growth in children and adolescents — as well as long-term organ dysfunction. However, recent evolutions in treatment options offer promising novel and emerging therapeutics poised to truly revolutionize SCD care. On this episode of NP Pulse: The Voice of the Nurse Practitioner®, nurse practitioner (NP) specialists Sheryl Mitchell and Artangela Henry guide NPs to achieve the following learning objectives:

Describe the epidemiologic patterns, pathophysiologic principles and robust patient burden of SCD.
Examine current best practices for SCD diagnosis, highlighting the fundamental importance of early disease detection, characterization and linkage to treatment.
Evaluate the established and evolving therapeutic landscape for SCD, with a focus on recent regulatory approvals and emerging trial data for novel agents.
Design individualized, evidence-driven treatment plans for patients with SCD that mitigate disease complications and improve quality of life.
Identify residual unmet needs in the SCD treatment paradigm and discuss the role of ongoing research and comprehensive, multidisciplinary care strategies in closing these gaps.

This program and the accompanying clinical resource tool were made possible by a medical education grant from Vertex.

Continuing education (CE) credit for this program may be claimed through Dec. 31, 2025. To claim credit for this program, log in to the CE Center, search for this program by name and complete the post-test and evaluation by entering the participation code that is given after listening to the podcast.

Describe the epidemiologic patterns, pathophysiologic principles and robust patient burden of SCD.
Examine current best practices for SCD diagnosis, highlighting the fundamental importance of early disease detection, characterization and linkage to treatment.
Evaluate the established and evolving therapeutic landscape for SCD, with a focus on recent regulatory approvals and emerging trial data for novel agents.
Design individualized, evidence-driven treatment plans for patients with SCD that mitigate disease complications and improve quality of life.
Identify residual unmet needs in the SCD treatment paradigm and discuss the role of ongoing research and comprehensive, multidisciplinary care strategies in closing these gaps.

This program and the accompanying clinical resource tool were made possible by a medical education grant from Vertex.

Previous Episode

132. LARC: Making the Case for Long-Acting Reversible Contraception (CE)

Making the Case for Long-Acting Reversible Contraception (CE)
Long-acting reversible contraception (LARC) is a very effective means of preventing an unintended pregnancy. The CDC recommends that clinicians provide patients with information about the effectiveness of all contraceptive options that they are medically eligible for. However, primary care providers and nurse practitioners report discussing LARC in less than half of their contraceptive counseling encounters. On today’s episode, nurse practitioners Barb Dehn and Dr. Joan Zaccardi discuss the vital role of the NP in contraceptive counseling and the importance of including LARC as a contraceptive option.
A participation code will be provided at the END of the podcast – make sure to write this code down. One you have listened to the podcast and have the participation code, return to this activity in the CE Center. Click on the "Next Steps" button of the activity and

Enter the participation code that was provided
Complete the post-test
Complete the activity evaluation
This will award your CE credit and certificate of completion. 0.75 CE, 0.5 RX, will be available through December 31, 2025.

This activity is partially supported by an educational grant from CooperSurgical. The remainder is funded by AANP.

Resources: U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (cdc.gov)

Next Episode

134. Exploring the Newest Cardiovascular Guidelines

On this episode, Margaret “Midge” Bowers returns to NP Pulse to discuss all things cardiovascular, with a focus on the newest atrial fibrillation and congestive heart failure guidelines. Bowers and Sophia Thomas also discuss new medications, the importance of communication between patient and provider — and why it is so necessary for NPs to “treat the person, not the number.”

If you are interested in learning more from Midge on this subject, listen to NP Pulse episode 106. Four Pillars of Medications for Heart Failure with Reduced Ejection Fraction and gain CE credit by going to the AANP CE Center here. CE credit is offered until February 2025.

Please also consider joining the AANP Community group: Cardiology Specialty Practice, which offers the opportunity to interactively collaborate with colleagues who share interest or clinical expertise on the subject.

NP Pulse: The Voice of the Nurse Practitioner (AANP) - 133. Sickle Cell Disease: Shifting Paradigms in Optimal Management for NPs (CE)

Transcript

00:00:12.791

From the American Association of Nurse Practitioners, I am nurse practitioner, nurse midwife, and AANP education specialist Cammie Hauser. I would like to welcome you to this edition of NP Pulse, the voice of the nurse practitioner.

00:00:32.957

NP Pulse is AANP’s official podcast, bringing unique nurse practitioner voices and expertise on issues that matter to NPS and to our patients. As always, be sure to subscribe to this podcast, share with yo